Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Plasmafit® Revision Structan® Hip Endoprosthesis Cup

NCT: NCT04255966 · ACTIVE_NOT_RECRUITING

NCT IDNCT04255966
StatusACTIVE_NOT_RECRUITING
Start Date2021-04-12
Completion2027-06

Brief Summary

The aim of this observational study is to collect clinical and radiological results of the new Plasmafit® Revision Structan® Hip Endoprosthesis Cup in a standard patient population and when used in routine clinical practice.

Frequently Asked Questions

What is Plasmafit® Revision Structan® Hip Endoprosthesis Cup?

Plasmafit® Revision Structan® Hip Endoprosthesis Cup is a clinical trial registered under NCT04255966. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04255966?

The current status of NCT04255966 (Plasmafit® Revision Structan® Hip Endoprosthesis Cup) is: ACTIVE_NOT_RECRUITING.

When did Plasmafit® Revision Structan® Hip Endoprosthesis Cup start?

Plasmafit® Revision Structan® Hip Endoprosthesis Cup started on 2021-04-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑